BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23621609)

  • 1. Editorial comment to effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: implications for multimodal therapy.
    Gudbjartsson T
    Int J Urol; 2013 Jun; 20(6):579. PubMed ID: 23621609
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment.
    Klatte T
    J Urol; 2009 Dec; 182(6):2606. PubMed ID: 19836796
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment.
    Pomara G; Francesca F
    Urology; 2011 May; 77(5):1146; author reply 1146-7. PubMed ID: 21539964
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment.
    Russo P
    Urology; 2010 Feb; 75(2):275-6; author reply 276. PubMed ID: 20152477
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment.
    Uzzo RG
    J Urol; 2009 Nov; 182(5):2171. PubMed ID: 19758642
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment.
    Russo P
    Urology; 2009 May; 73(5):1082. PubMed ID: 19394510
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Eggener S
    Eur Urol; 2010 Mar; 57(3):472. PubMed ID: 19359087
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Russo P
    Eur Urol; 2010 Mar; 57(3):472-3. PubMed ID: 19359086
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of surgery (cytoreductive nephrectomy and metastasectomy) in the management of metastatic renal cell carcinoma: a literature review].
    Arroua F; Maurin C; Carcenac A; Ragni E; Rossi D; Bastide C
    Prog Urol; 2010 Dec; 20(13):1175-83. PubMed ID: 21130395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment.
    Singer EA; Srinivasan R; Bratslavsky G
    J Urol; 2011 Jan; 185(1):66. PubMed ID: 21074200
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
    Karam JA; Wood CG
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):753-64. PubMed ID: 21763966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy.
    You D; Jeong IG; Ahn JH; Lee DH; Lee JL; Hong JH; Ahn H; Kim CS
    J Urol; 2011 Jan; 185(1):54-9. PubMed ID: 21074811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment.
    Campbell SC; Lane BR
    J Urol; 2010 Feb; 183(2):485; discussion 485. PubMed ID: 20006871
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment.
    Akhtar NH; Tagawa ST
    J Urol; 2011 Jan; 185(1):59. PubMed ID: 21074812
    [No Abstract]   [Full Text] [Related]  

  • 15. [What is the impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?].
    Oya M; Murai M
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1732-7. PubMed ID: 12402422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
    Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
    J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
    Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
    J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial comment on: external validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Blute ML
    Eur Urol; 2010 Jan; 57(1):110-1. PubMed ID: 19062158
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment on: External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Giannarini G; Autorino R
    Eur Urol; 2010 Jan; 57(1):109-10. PubMed ID: 19062156
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment.
    Shichman SJ
    Urology; 2010 Feb; 75(2):281. PubMed ID: 20152480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.